4th Quarter - Report

MICHAEL N. MCCARTY LAW OFFICE PLLC for AMERICAN MEDICAL TECHNOLOGISTS

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Legislation affecting payments under the Medicare Clinical Laboratory Fee Schedule; coronavirus relief and stimulus legislation as it affects payment for clinical laboratory testing services. Oppose the Strictly Pay for Efficient and Expedited Delivery of Your (SPEEDY) COVID-19 Tests Act (H.R. 8496).

LobbyistCovered position, as disclosed
MICHAEL N MCCARTY —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8496 (116th)

Medical/Disease Research/Clinical Labs MED

Legislation to regulate in vitro clinical diagnostic tests, including the Verifying Accurate, Leading-edge IVCT Development (VALID) Act (H.R.6102; S.3404); and the Verified Innovative Testing in American Laboratories (VITAL) Act (S.3512); Coronavirus relief and stimulus legislation as it relates to clinical laboratories and medical practices; coronavirus testing and vaccine supply chain issues.

LobbyistCovered position, as disclosed
MICHAEL N MCCARTY —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 6102 (116th), S. 3404 (116th), S. 3512 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.